Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1982-05-17
1984-03-20
Chan, Nicky
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
424283, C07D31178
Patent
active
044382740
ABSTRACT:
The present specification provides novel analogs of khellin, a natural product, which are useful in the treatment and prevention of atherosclerosis. Particularly, the present disclosure provides novel 5H-furo[3,2-g]-benzopyran-5-one substituted at the four and nine positions by methoxy or optionally substituted at the four position by hydroxy or alkoxy groups other than methoxy, certain 7-(N,N-dialkylaminoethen-2-yl substituted compounds. Also provided are certain novel antiatherosclerotic 7H-furo[3,2-g][1]benzopyrans.
REFERENCES:
patent: 2680119 (1954-06-01), Robertson et al.
patent: 4284569 (1981-08-01), Gammill
Abu-Shady, H., Experiments with Khellin VII., UAR J. Pharm. Sci., 11:283-288 (1970).
Abu-Shady, H., et al., Experiments with Khellin-VIII. J. Pharm. Belg., 33:397-399 (1978).
Anrep, G. V., et al., Therapeutic Uses of Khellin, The Lancet, pp. 557-558 Apr. 26, 1947.
Anrep, G. V., et al., The Coronary Vasodilator Action of Khellin, Amer. Heart J., 37:531-542 (1949).
Apffel, C. A., Die Zytostatische Wirkung von Chinonen und Ihren Derivaten, Deut. Med. Wochschr., 80:414-416 (1955).
Aubertin, E., La Khelline, agent de relachement de la musculature lisse. J. Med. Bordeaux, 127:821-823 (1950).
Baytop, O. T., Khellin'in Yer Solucanlarina Tesiri Hakkinda, Folia Pharm. (Turkey), 1:48-49 (1949).
Best, M. M., et al., Effects of dioxyline Phosphate and Enteric-Coated Khellin on Coronary Artery Insufficiency, Amer. J. Med. Sci. 222:35-39 (1951).
Chen, G., et al., The Central Nervous Depressive Effect of Khellin, Proc. Soc. Expetl. Biol. Med., 78:305-307 (1951).
Colombo, G., et al., Sulla attivita di alcune sostanze del gruppo della Kellina sulla motilita ureterale--in vitro--, Arch. Sci. Med. 97:71-81 (1954).
Day, C. E., et al., Utility of a Selected Line (SEA) of the Japanese Quail for the Discovery of New Anti-Atherosclerosis Drugs, Laboratory Animal Science, 27:817-821 (1977).
Easton, R. P., High Density Lipoprotein--Key to Anti-Atherogenesis, J. Chron. Dis., 31:131-135 (1978).
Haust, M. D., Reaction Patterns Of Intimal Mesenchyme to Injury, and Repair in Atherosclerosis, Adv. Exp. Med. Biol., 43:35-57 (1974).
Huttrer, C. P., et al., The Chemistry and Physiological Action of Khellin and Related Products, Chem. Revs., 48:543-579 (1951).
Jordan, H., Cardiovasculare Wirkungen Intravenoser Khellin-Injektionen, Arzneimittel-Forsch 8:141-143 (1958).
Jordan, H., Cardiovasculare Wirkungen Intravenoser Khellin-Injektionen, Arzneimittel-Forsch, 7:82-85 (1957).
LaBarre, J., et al., Action protectrice de la khelline vis-a-vis de pulcere gastrique experimental provoque, chez le chien, par l'administration de cinchophene, Compt. Rend. Soc. Biol., 150:598-599 (1956).
LaBarre, J., et al., A propos de l'action inhibitrice de la khelline dans l'ulcere gastrique experimental provoque par administration journaliere de phenylbutazone, Compt. Rend. Soc. Biol., 150:1806-1807 (1956).
Lian, C., et al., Etude Experimentale et Clinique de la Khelline, Acta. Cardiol. (Brussels), 5:373-388 (1950).
Montorsi, W., et al., Sur L'Activite de Certaines Substances du Groupe de la Khelline, Presse Med., 63:81 1955).
Musante, C., et al., Furil E. Isossazol-Furo-Cromoni e Derivati, Pharmaco. (Pavie) Ed. Sci., 15:81-94 (1960).
Mustafa, A., et al., Experiments with Furochrmones, Synthesis of Ammiol and Khellol, J. Org., Chem., 26:886-890 (1961).
Mustafa, A., Furopyrans and Furopyrones, John Wiley and Sons, Inc., NY (1967) pp. 102-159 (Chapter III: Furochromones).
Osher, H. L., et al., Khellin in the Treatment of Angina Pectoris, New England J. Med., 244:315-321 (1951).
Raymond-Hamet, M., Compt. Rend., 238:1624-1626 (1954).
Samaan, K., et al., The Response of the Heart to Visammin and to Khellinin, J. Pharm. Pharmacol., 1:538-544 (1949).
Samaan, K., et al., The Existence in Ammi Visnaga of a Cardiac Depressant Principle Visammin and a Cardiac Stimulant Glycoside Khellinin, J. Roy, Egypt Med. Assoc., 33:953-960 (1950).
Schonberg, A., et al., Khellin and Allied Compounds, JACS 72:1611-1617 (1950).
Schonberg, et al., Furo-Chromones and -Coumarins. XIV. JACS 77:5439-5440 (1955).
Schurr, P. E., High Volume Screening Procedure for Hypobetalipoproteinemia Activity in Rats, Adv. Exp. Med. Biol. 67: Atherosclerotic Drug Discovery, pp. 215-229, Plenum Press (1975).
Silber, E. N., The Effect of Khellin on Cardio-Pulmonary Function in Chronic Pulmonary Disease, published in 1951.
Swayne, V. R., et al., Spermicidal Action of Khellin, Amer. J. Pharm., 125:295-298 (1953).
Armitage Robert A.
Chan Nicky
The Upjohn Company
Welch Lawrence T.
LandOfFree
Antiatherosclerotic furochromones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiatherosclerotic furochromones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiatherosclerotic furochromones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1605470